Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CEN BIOTECH INC (CENBF)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 21.1% | 35.9% | 7.1% | 7.0% | 5.9% | 5.2% | 8.1% | 19.6% |
| Gross profit | 78.9% | 64.1% | 92.9% | 93.0% | 94.1% | 94.8% | 91.9% | 80.4% |
| General and administrative | 1262.4% | 1152.3% | 94.3% | 95.0% | 6.3% | 5.3% | 26.4% | 24.6% |
| EBITDA | -166.2% | -165.6% | -101.4% | -104.4% | -84.6% | -87.5% | -52.2% | -49.9% |
| Depreciation | 2.9% | 2.8% | 0.2% | 0.1% | 0.1% | | | |
| EBITA | -169.1% | -168.4% | -101.6% | -104.6% | -84.6% | -87.5% | -52.3% | -50.2% |
| Amortization of intangibles | 28.2% | 21.6% | 2.3% | 2.5% | 2.2% | 2.1% | 11.5% | 10.1% |
| EBIT | -197.4% | -190.0% | -103.9% | -107.0% | -86.8% | -89.6% | -63.8% | -60.2% |
| Pre-tax income | -226.6% | -227.3% | -102.5% | -103.0% | 14.4% | 8.6% | 420.9% | 337.3% |
| Income taxes | -2.6% | -2.4% | -0.2% | -0.2% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -224.0% | -224.9% | -102.3% | -106.3% | 11.3% | 5.5% | 404.1% | 337.3% |
|